Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Insmed Inc Virtual R&D Day Transcript

Sep 30, 2020 / 02:00PM GMT
Release Date Price: $32.14 (-1.88%)
Operator

Good morning, and welcome to the Insmed's R&D Day Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Sara Bonstein. Please go ahead.

Sara M. Bonstein
Insmed Incorporated - CFO

Good morning, and thank you for joining us for Insmed's R&D Day, where we will share exciting updates across our pipeline. The slides from today's presentation will be made available on our website shortly after the presentation is concluded.

During today's presentation, you will be hearing from various members of the Insmed leadership team around some meaningful corporate advances. Importantly, we believe we have funding to cover our current planned programs over the next 3 years, which you'll hear about today.

You will first hear from Will Lewis, Chair and Chief Executive Officer of Insmed. Following his comments, we will turn to Dr. Eugene Sullivan, Chief Product Strategy Officer at Insmed; as well as Dr. Ronald Oudiz, an internationally recognized expert in pulmonary

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot